BRC Q2 FY26 net loss narrows to $0.2 million; revenue rises 12.8% to $107 million
Reuters2026/08/03 20:27- BRC reported Q2 2026 net loss of USD 0.2 million, narrowing from USD 14.5 million a year earlier; adjusted EBITDA rose to USD 6.3 million.
- Net revenue increased 12.8% year over year to USD 107 million, driven by 15.2% wholesale growth to USD 70.6 million.
- Direct-to-consumer revenue climbed 13.6% to USD 31.4 million, while Outposts revenue fell 15% to USD 5 million.
- Gross margin improved 0.2 percentage points to 34.1% on pricing actions, lower shipping and fulfillment costs, and a smaller excess-inventory reserve.
- Maintained full-year 2026 outlook for at least 8% revenue growth, gross margin of 34% to 36%, and at least 35% adjusted EBITDA growth.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GE HealthCare (GEHC.US) plans to acquire Sofie for $1 billion, aiming for high growth in the radiopharmaceutical sector
GE Healthcare plans to acquire Sofie for about $1 billion, aiming to expand recurring revenue by combining imaging devices with radiodiagnostic agents, in response to weak stock performance and pressure from activist investors.

Silver Price Forecast: XAG/USD bears have the upper hand below $64.75-$64.85 confluence
Resonac Holdings says RESONAC REPORT 2026 integrated report now available
Japanese Yen edges lower vs USD amid Middle East jitters as Fed, BoJ meetings loom